Salih Kilic

Salih Kilic

Auto-generated profile, based on publicly available information

Salih Kilic

Department of Cardiology, Adana Training and Research Hospital, University of Health Sciences, Adana, Turkey

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
SKSalih Kilic
Salih Kilic
Myocardial infarction (MI) with non-obstructive coronary arteries (MINOCA) is a relatively new term that is characterized by clinical evidence of MI with normal or near-normal coronary arteries on coronary angiography (QCA). To date, there have been no population-based studies on the prevalence of MINOCA in Turkey. The aim of this nationwide study was to document the prevalence and demographics of MINOCA in a Turkish population. MINOCA-TR is national, multi-center, prospective, all-comer study that was conducted in 32 hospitals. All consecutive patients who were ≥18 years old, diagnosed with MI according to the Third Universal Definition of Myocardial Infarction, and had undergone QCA were included in the study. Patients with stable coronary artery disease, unstable angina pectoris, a history of revascularization, and type 4/5 MI were excluded. A total of 1793 patients who were diagnosed with MI and had undergone QCA were screened between March 2018 and October 2018, of whom 1626 (mean age: 61.5±12.5 years, 70.7% male) were enrolled from 32 centers. The prevalence of MINOCA was 6.7% (n=109) in the overall study population. Compared with non-MINOCA patients, those with MINOCA were younger, had a higher prevalence of the female gender, and had a history of flu. The percentages of current smokers, ST-segment elevated myocardial infarction patients, and those with a history of hypertension, diabetes mellitus, and hyperlipidemia were significantly lower in MINOCA patients (p<0.05, for all). Also, the median left ventricular ejection fraction as seen on echocardiography and the ratio of Killip Class I status at presentation was significantly higher in MINOCA patients than in non-MINOCA patients (p<0.001). Patients with MINOCA received a preload dose of P2Y12 antagonist before QCA less often than non-MINOCA patients (p<0.001). The prevalence of MINOCA in Turkey is 6.7% in patients who were admitted with MI. Also, as compared to non-MINOCA patients, the MINOCA patients were exposed to fewer traditional risk factors of coronary artery disease.

1 February 2021 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
AYArafat Yildirim
Arafat Yildirim
MKMehmet Kucukosmanoglu
Mehmet Kucukosmanoglu
NKNermin Yıldız Koyunsever
Nermin Yıldız Koyunsever
YÇYusuf Çekici
Yusuf Çekici
MBMehmet Cenk Belibağlı
Mehmet Cenk Belibağlı
SKSalih Kılıc
Salih Kılıc
The aim of this study was to investigate the performance of controlling nutritional status (CONUT) index, geriatric nutritional risk index (GNRI), and prognostic nutritional index (PNI) scores in predicting the long-term prognosis of patients with non-ST-elevated myocardial infarction (NSTEMI) who underwent percutaneous coronary intervention (PCI). A total of 915 patients with NSTEMI (female: 48.4%; mean age: 73.1±9.0 years) who underwent PCI at Adana Numune Training and Research Hospital, Cardiology Clinic between January 2014 and January 2015 were included in this cross-sectional and retrospective study. CONUT, GNRI, and PNI scores were calculated based on the admission data derived from samples of peripheral venous blood. The mean follow-up duration was 64.5±15.4 months. During follow-up (mean 64.5±15.4 months), 179 patients (19.6%) died. The mean GNRI and PNI scores were significantly lower in the nonsurvivor group; however, the median CONUT score was significantly higher in the nonsurvivor group compared with the survivor group. The receiver operating characteristic (ROC) curve analyses have shown that GNRI score has similar performance to the CONUT score and has better performance than PNI score in predicting 5-year mortality. The Kaplan-Meier curve analysis has shown that patients with lower PNI or GNRI had higher cumulative mortality than the patients with higher PNI or GNRI. Also, the patients with higher CONUT scores had higher cumulative mortality compared with those with lower scores. The multivariate analyses have shown that GNRI (HR: 0.973), PNI (HR: 0.967), CONUT score (HR: 1.527), and body mass index (BMI) (HR: 0.818) were independent predictors of the 5-year mortality in patients with NSTEMI. In this study, we have shown that CONUT score, GNRI, and PNI values were associated with the long-term mortality in patients with NSTEMI who underwent PCI, and GNRI yielded similar results to CONUT score but was better than PNI.

1 October 2018 in Atherosclerosis
Verified
Journal Article
Closed access
MKMeral Kayikcioglu
Meral Kayikcioglu
LTLale Tokgozoglu
Lale Tokgozoglu
VDVolkan Dogan
Volkan Dogan
CCCeyhun Ceyhan
Ceyhun Ceyhan
ATAbdullah Tuncez
Abdullah Tuncez
LCLevent H. Can
Levent H. Can

25 September 2022 in Angiology
Verified
Journal Article
Closed access
MDMustafa Dogdus
Mustafa Dogdus
FDFerhat Dindas
Ferhat Dindas
MYMustafa Yenercag
Mustafa Yenercag
AYArafat Yildirim
Arafat Yildirim
ÖAözge özcan abacıoğlu
özge özcan abacıoğlu
OCOzkan Candan
Ozkan Candan
As inflammation plays a significant role in the development of coronary artery disease, we hypothesized that there may be a relation between the systemic immune inflammation index (SII) and saphenous vein graft disease (SVGD). The study population consisted of 716 consecutive patients who underwent elective coronary angiography (CAG) >1 year after bypass grafting. The patients were divided into 2 groups depending on the extent of SVG patency. SII value was significantly higher in the SVGD(+) group compared with the SVGD(−) group ( P < .001). In multivariate logistic regression analysis, SII ( P < .001, odds ratio (OR) = 3.27, 95% CI = 1.94–5.65) and neutrophil-to-lymphocyte ratio (NLR) ( P < .001, OR = 2.08, 95% CI = 1.59–3.11) were found to be independent predictors of SVGD. An SII value of >935 (x10 3 /ml) has 89.2% sensitivity and 70.6% specificity for the prediction of the SVGD, and an NLR value of >4.15 has 54.6% sensitivity and 68.5% specificity for the prediction of the SVGD. The AUC of SII was found to be greater than the AUC of NLR ( P = .002), platelet-to-lymphocyte ratio (PLR) ( P = .009), lymphocyte-to-monocyte ratio (LMR) ( P = .013), MPV ( P = .011), and C-reactive protein (CRP) ( P = .034) in predicting SVGD. In conclusion, we demonstrated that SII, which is among the new inflammation indexes, is a more reliable predictor in determining SVGD than the NLR, PLR, and LMR.

6 May 2021 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
MDMustafa Dogdus
Mustafa Dogdus
FDFerhat Dindas
Ferhat Dindas
OAOnur Akhan
Onur Akhan
MYMustafa Yenerçağ
Mustafa Yenerçağ
AYArafat Yildirim
Arafat Yildirim
SKSalih Kilic
Salih Kilic

10 January 2019 in Balkan Medical Journal
Verified
Journal Article
Open access
SKSalih Kılıç
Salih Kılıç
ACAhmet Celik
Ahmet Celik
EÇElif Çekirdekçi
Elif Çekirdekçi
SAServet Altay
Servet Altay
DEDeniz Elcik
Deniz Elcik
MZMehdi Zoghi
Mehdi Zoghi
Background: The use of warfarin and aspirin combination is restricted for limited patients in relevant guidelines.Aims: The aim of this study is to evaluate the prevalence of inappropriate combination of aspirin and warfarin therapy in daily practice and its risks.Study Design: Cross-section study.Methods: WARFARIN-TR study is a multi-center observational study that includes 4987 patients using warfarin for any reason between January 1, 2014 and December 31, 2014. To determine the prevalence of inappropriate combination use in daily practice, all patients who had a history of atherosclerotic disease (ischemic heart disease, peripheral artery disease) or cerebrovascular disease (n=1498) were excluded. The data of 3489 patient were analyzed. We defined inappropriate combination, all patients who received aspirin and warfarin regardless of warfarin use indication, in the direction of the ESC guidelines recommendation.Results: The mean age of the patients was 59.2±13.8 years (41.8% male). The prevalence of inappropriate warfarin and aspirin combination was found as 20.0%. The prevalence of combination therapy in patients with a primary indication for mechanical heart valve, non-valvular atrial fibrillation MHV, and other reason was 20.5%, 18.7% and 21.0%, respectively. Multivariate logistic regression analysis revealed that age (OR, 1.009; 95% CI, 1.002-1.015; p=0.010), HF (OR, 1.765; 95% CI, 1.448-2.151; p<0.001), smoking (OR, 1.762; 95% CI, 1.441-1.153; p<0.010), CKD (OR, 2.057; 95% CI, 1.494-2.833; p<0.001), and deep vein thrombosis (OR, 0.463; 95% CI, 0.229-0.718; p=0.001) were independent predictors of the combination therapy (R2=0.66 ). The mean Time in Therapeutic Range (TTR) of patients receiving combination therapy was significantly lower tan those in warfarin mono-therapy (51.6±27.05 vs. 54.7±23.93; p=0.006). Totally, 19.4% (n=677) of the patients had a bleeding event (major bleeding 13.0%, n=88) within a year. Percentages of patients with combination therapy were significantly higher in patients with major bleeding than patients without major bleeding (29.5% vs. 19.7%; P=0.023).Conclusion: Our study demonstrated that 20.0% of the patients taking warfarin use concomitant aspirin inappropriately in daily practice. Patients receiving aspirin with warfarin were demonstrated to have more comorbidities, lower TTR levels, and higher rates of bleeding.